Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Total revenue	$ 16,543,571	$ 17,837,906
Total cost of revenue	2,912,987	2,977,904
Gross profit	13,630,584	14,860,002
Operating expenses:
Research and development costs	3,208,921	3,913,337
Selling and marketing	4,337,054	4,453,697
General and administrative	5,635,273	5,278,768
Restructuring costs	1,104,318	1,261,578
Total operating expenses	14,285,566	14,907,380
Operating loss	(654,982)	(47,378)
Interest and other expense	(604,647)	(626,048)
Loss before income taxes	(1,259,629)	(673,426)
Income tax expense	492,325	233,288
Net loss	(1,751,954)	(906,714)
Less: Accrual of Series A redeemable convertible preferred stock dividends	1,157,762	1,035,977
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	389,811	254,212
Less: Deemed dividend on Series A redeemable convertible preferred stock	0	2,269,042
Net loss attributable to common stockholders	$ (3,299,527)	$ (4,465,945)
Earnings per share
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.56)	$ (4.79)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.56)	$ (4.79)
Weighted average basic shares outstanding (in shares)	5,900,621	933,301
Weighted average diluted shares outstanding (in shares)	5,900,621	933,301
Product
Total revenue	$ 6,767,595	$ 5,766,532
Total cost of revenue	721,122	414,149
Support and service
Total revenue	9,775,976	12,071,374
Total cost of revenue	$ 2,191,865	$ 2,563,755